SuspendedEarly Phase 1ACTRN12615000236594

Electromagnetic Millimetre Wave Therapy for pain relief

Comparing pain levels before and after Electromagnetic Millimetre Wave Therapy (EMT) in patients presenting with chronic pain


Sponsor

National Institute of Integrative Medicine

Enrollment

40 participants

Start Date

Aug 3, 2015

Study Type

Interventional

Conditions

Summary

Electromagnetic Millimetre Wave Therapy (EMT), originally developed in Russia, has shown promise in pain relief therapy in several randomised controlled trials conducted in the USA and Europe in the last 15 years. EMT was shown to be effective in reducing painful conditions, including joint pain, headache, postoperative pain, and neuropathic pain. Aims of this study In this study, we want to find out: 1. The effect of EMT on pain relief 2. The effect of EMT on pain related quality of life 3. The duration of pain relief by EMT 4. The tolerability of EMT The proposed study will be a preliminary investigation of the effectiveness of EMT in pain relief. Data will inform the proposal for a larger cohort study. Patients, presenting with chronic pain and attending the NIIM clinic, will be approached to participate. Pain levels and locations will be variable, in this pilot phase. Consenting patients will be treated with EMT therapy for 15 minutes. Subjective pain levels, and the impact on the quality of life will be assessed at baseline, shortly after EMT treatment, and at regular intervals for three days after the clinical session, using validated pain scales.


Eligibility

Sex: Both males and femalesMin Age: 18 YearssMax Age: 80 Yearss

Inclusion Criteria1

  • Adults 18-80 years, presenting with pain experienced for at least 1 month

Exclusion Criteria1

  • acute pain (< 1 month)

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Electromagnetic Millimetre Wave Therapy (EMT), originally developed in Russia, has shown promise in pain relief therapy in several randomised controlled trials conducted in the USA and Europe in the l

Electromagnetic Millimetre Wave Therapy (EMT), originally developed in Russia, has shown promise in pain relief therapy in several randomised controlled trials conducted in the USA and Europe in the last 15 years. EMT was shown to be effective in reducing painful conditions, including joint pain, headache, postoperative pain, and neuropathic pain. EMT involves a local exposure of the skin (2-3 cm2) to low power electromagnetic waves (<20mW/cm2) in the millimetre range (30-300GHz). Phase 1: Consenting patients will holds the device on Day 1 once for 15 minutes either to the localised area of pain or, in case of systemic pain, to the sternum. Phase 2: Treatment is to be repeated 4x a week on every 2nd day as per protocols in the literature. EMT may have three main effects: (i) sedative and analgesic; (ii) anti-inflammatory action and enhancement of tissue generation processes and (iii) immune stimulation.


Locations(1)

VIC, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12615000236594